Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 26, 2022, titled “Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure……
| Subscribe To Our Free Newsletter |
